AI test aims to predict best cancer drugs for patients
NCT ID NCT05478538
Summary
This study is testing a new diagnostic platform called Cybrid that uses artificial intelligence to analyze small pieces of a patient's tumor. The goal is to see if this test can better predict which lung cancer patients will respond to immunotherapy drugs compared to current methods. Researchers will enroll 200 people with advanced non-small cell lung cancer and compare the test's predictions to how patients actually respond to treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NSCLC NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Baylor Scott & White Research Institute
RECRUITINGTemple, Texas, 76508, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Gabrail Cancer Center
TERMINATEDCanton, Ohio, 44718, United States
-
JPS Health Network
RECRUITINGFort Worth, Texas, 76104, United States
Contact Email: •••••@•••••
Contact
-
James M Stockman Cancer Institute
RECRUITINGFrederick, Maryland, 21702, United States
Contact
Contact Email: •••••@•••••
-
New York Cancer & Blood Specialists
RECRUITINGShirley, New York, 11967, United States
Contact Email: •••••@•••••
Contact
-
UCLA Medical Center
RECRUITINGLos Angeles, California, 90095, United States
Contact
Contact Email: •••••@•••••
-
University of North Carolina at Chapel Hill
TERMINATEDChapel Hill, North Carolina, 27599, United States
Conditions
Explore the condition pages connected to this study.